Novel antiviral compounds fight wide range of viruses

Kineta, Inc., a biotechnology company that creates immune modulating drugs, recently released data from its studies that show its new antiviral compounds prevent subjects from contracting a broad range of viruses, like Ebola, that are both current and emerging. Read More »

TB cases down slightly, but health officials still concerned

Washington's tuberculosis (TB) rates decreased 8 percent in 2014, but state and local health professionals remain concerned about the illness. Read More »